| 产品名称： | Penicillium griseofulvum Dierckx, anamorph |
|---|---|
| 商品货号： | TS184152 |
| Deposited As： | Penicillium urticae Bainier, anamorph |
| Strain Designations： | S11R59 |
| Application： | produces patulolide A produces patulolide B produces patulolide C produces patulolide C oxidase produces patulolides |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions： | Temperature: 24.0°C |
| Name of Depositor： | Y Yamada |
| Chain of Custody： | ATCC < |
| Isolation： | derived from ATCC 48165 |
| References： | Rodphaya D, et al. Oxidases involved in biosynthesis of macrolide antibiotic patulolides from Penicillium urticae S11R59. J. Antibiot. 42: 752-760, 1989. PubMed: 2722690 Rodphaya D, et al. Biosynthesis of the macrolide antibiotic patulolides by Penicillium urticae S11R59: identification of the origin of carbon atoms by 13C NMR spectroscopy. J. Antibiot. 41: 1649-1658, 1988. PubMed: 3198497 Rodphaya D, et al. New macrolides from Penicillium urticae mutant S11R59. J. Antibiot. 39: 629-635, 1986. PubMed: 3733512 Makita A, et al. The total synthesis of (+)-patuolide A. J. Antibiot. 39: 1257-1262, 1986. PubMed: 3781924 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Penicillium griseofulvum Dierckx, anamorph |
|---|---|
| 商品货号： | TS184152 |
| Deposited As： | Penicillium urticae Bainier, anamorph |
| Strain Designations： | S11R59 |
| Application： | produces patulolide A produces patulolide B produces patulolide C produces patulolide C oxidase produces patulolides |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Type Strain： | no |
| Preceptrol®： | no |
| Medium： | ATCC® Medium 325: Malt extract agar (Blakeslees formula) |
| Growth Conditions： | Temperature: 24.0°C |
| Name of Depositor： | Y Yamada |
| Chain of Custody： | ATCC < |
| Isolation： | derived from ATCC 48165 |
| References： | Rodphaya D, et al. Oxidases involved in biosynthesis of macrolide antibiotic patulolides from Penicillium urticae S11R59. J. Antibiot. 42: 752-760, 1989. PubMed: 2722690 Rodphaya D, et al. Biosynthesis of the macrolide antibiotic patulolides by Penicillium urticae S11R59: identification of the origin of carbon atoms by 13C NMR spectroscopy. J. Antibiot. 41: 1649-1658, 1988. PubMed: 3198497 Rodphaya D, et al. New macrolides from Penicillium urticae mutant S11R59. J. Antibiot. 39: 629-635, 1986. PubMed: 3733512 Makita A, et al. The total synthesis of (+)-patuolide A. J. Antibiot. 39: 1257-1262, 1986. PubMed: 3781924 |
